These outcomes, along with a former report displaying that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like conduct in mice,2 support the concept of focusing on ACKR3 as a unique way to modulate the opioid method, which could open new therapeutic avenues for opioid-relevant Conditions.We independently exploration, critique, and suggest